Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response

Summary

BM32 is a product for immunotherapy of grass pollen allergies. It consists of 4 different recombinant proteins (BM321, BM322, BM325 and BM326) adsorbed on alhydrogel. This prospective, double-blind. placebo controlled, mono-centric trial investigates the levels of allergen specific IgG antibodies following 3, 4 or 5 subcutaneous injections before the grass pollen season.

Timeline

Start

2016-01

Primary completion

2016-10

Completion

2017-01

Drugs

Indications